Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.6 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition 89676a69-1fe7-422c-ab00-92abe4ef6ea9
identifier: Example2BeadDrug
combinedPharmaceuticalDoseForm: CAPSULE
route: ORAL
name
productName: OXAZEPAM 30mg, PROPRANOLOL HYDROCHLORIDE 60mg
type: Non-Proprietary
part
part: OXAZEPAM
type: scientific name
part
part: 30mg
type: OXAZEPAM
part
part: PROPRANOLOL HYDROCHLORIDE
type: scientific name
part
part: 60mg
type: PROPRANOLOL HYDROCHLORIDE